Hummingbird ICE Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPhilips Clinical & Medical Affairs Global

About this trial

The goals of this observational study are to collect data and ultrasound images using the Philips VeriSight Pro intracardiac echocardiography (ICE) catheter to assess safety and effectiveness and to support development efforts of the VeriSight Pro imaging platform.

Eligibility criteria

Qualifiers

18 years of age

Willing to provide written, dated and signed, informed consent

Undergoing percutaneous cardiac intervention procedures in with VeriSight Pro is used

Disqualifiers

Contraindicated for ICE catheter placement or considerations that make placement of VeriSight not technically feasible

Known contraindicated conditions include sepsis, major coagulation abnormalities, presence of any intracardiac thrombus, presence of class IV angina or heart failure, deep vein thrombosis, or significant peripheral vascular disease

Trial design

Treatments tested in this trial

  • ICE Image Guidance

Treatment groups

1,000 Participants
are divided into 1 treatment group

Locations

This trial has no locations